Aktuality

Levée de fonds de 100 millions USD pour notre client Oculis !

Patenty

Získání 100 milionů USD pro našeho klienta Oculis!

11 Březen, 2025

Denis Bourgarel

Společnost Oculis byla založena v prosinci 2017 a je globální biofarmaceutickou společností specializující se na oční a neurooftalmologické choroby, jejímž posláním je zachovat zrak a zlepšit péči o oči.

Toto nejnovější kolo financování posiluje pozici společnosti Oculis a umožňuje jí pokračovat v růstu a podporovat vývoj inovativních produktů proti očním chorobám.
V roce 2023 společnost Oculis oznámila vstup na americký trh Nasdaq U.S a následně v roce 2024 na Nasdaq Island.

Náš odborník Denis Bourgarel, partner, právník v oblasti průmyslového vlastnictví (IP) a evropský patentový zástupce, pomáhá společnosti Oculis s její strategií a operacemi v oblasti IP.

Gratulujeme této inovativní společnosti, která od svého založení skokově vyrostla!

Další informace na stránkách společnosti: https://oculis.com/

Ze stejné odbornosti
Od stejné/ho autora/ky

Ze stejné odbornosti

Allergen Alert, a deeptech company specializing in rapid food allergen detection for individuals and professionals, has raised €3.6 million in funding !

12 Listopad, 2025

Denis Bourgarel

Allergen Alert, deeptech spécialisée dans la détection rapide des allergènes alimentaires à destination des particuliers et des professionnels, a annoncé une levée de fonds de 3,6 millions d’euros !

This investment will enable the company to finalize the technical development of its solution and accelerate the industrialization of its production (...)

$45 million Series A funding round for our client Genomines

6 Listopad, 2025

Denis Bourgarel

$45 million Series A funding round for our client Genomines

Founded in 2021, Genomines is a deeptech startup that uses biotechnology to reinvent the mining industry. This funding will enable Genomines to (...)

Ipsen announces its intention to acquire ImCheck Therapeutics

4 Listopad, 2025

Denis Bourgarel

Ipsen announces its intention to acquire ImCheck Therapeutics

On October 22, 2025, the biopharmaceutical group Ipsen announced that it had entered into a definitive agreement to acquire ImCheck Therapeutics, a (...)

Cyra Nargolwalla, Bertrand Loisel, Eric Burbaud a Ina Schreiber se opět umístili v žebříčku IAM Global Leaders 2025

22 Květen, 2025

Cyra Nargolwalla, Bertrand Loisel, Eric Burbaud et Ina Schreiber reconnus une nouvelle fois par IAM Global Leaders 2025

Plasseraud IP s radostí oznamuje, že Cyra Nargolwalla, Bertrand Loisel, Eric Burbaud a Ina Schreiber byli znovu oceněni jako přední patentoví (...)

Plasseraud IP Strengthens Its European Presence with the Opening of a New Office in Amsterdam

9 Leden, 2025

Plasseraud IP renforce sa présence européenne avec l’ouverture d’un nouveau bureau à Amsterdam

Following its successful expansion into Munich, Shanghai, Prague, Madrid and Alicante, Plasseraud IP is pleased to announce the opening of its new (...)

See the Big Picture: How Patent Landscape Analysis Can Benefit Your Business

11 Prosinec, 2024

See the Big Picture: How Patent Landscape Analysis Can Benefit Your Business

At Plasseraud IP, we are pleased to introduce our Patent Landscape Analysis service, a powerful tool designed to provide you with valuable insights (...)

Cyra Nargolwalla, Bertrand Loisel, Eric Burbaud and Ina Schreiber recognized as IAM Global Leaders 2025

31 Říjen, 2024

Cyra Nargolwalla, Bertrand Loisel, Eric Burbaud and Ina Schreiber recognized as IAM Global Leaders 2025

Plasseraud IP is delighted to announce that Cyra Nargolwalla, Bertrand Loisel and Eric Burbaud, Managing Partners, have been recognized as leading (...)

Three experts from Plasseraud IP recognized Rising Stars 2024 by IP Stars-Managing IP

10 Říjen, 2024

Three experts from Plasseraud IP recognized Rising Stars 2024 by IP Stars-Managing IP

Plasseraud IP is delighted to announce the appointment of Charlotte Leleu, Charlotte Montaud and Nathalie Wajs as “Rising Stars 2024” by Managing IP (...)

Cyra Nargolwalla & Nadine Rocaboy once again recognized as World's Leading IP Strategists by IAM Strategy 300 in 2024

3 September, 2024

Cyra Nargolwalla

Cyra Nargolwalla & Nadine Rocaboy une nouvelle fois reconnues World’s Leading IP Strategists par IAM Strategy 300 en 2024

Plasseraud IP is pleased to announce the ranking of Cyra Nargolwalla and Nadine Rocaboy as internationally renowned IP experts in the IAM Strategy (...)

Romania joins the Unitary Patent System and the Unified Patent Court

2 September, 2024

La Roumanie rejoint le système du Brevet Unitaire et la Juridiction Unifiée du Brevet

As of September 1, 2024, Romania has officially become the 18th member of the Unitary Patent (UP) system and the Unified Patent Court (UPC). From (...)

Ze stejné odbornosti

Allergen Alert, a deeptech company specializing in rapid food allergen detection for individuals and professionals, has raised €3.6 million in funding !

20 Listopad, 2025

Denis Bourgarel

Allergen Alert, deeptech spécialisée dans la détection rapide des allergènes alimentaires à destination des particuliers et des professionnels, a annoncé une levée de fonds de 3,6 millions d’euros !

This investment will enable the company to finalize the technical development of its solution and accelerate the industrialization of its production (...)

$45 million Series A funding round for our client Genomines

19 Listopad, 2025

Denis Bourgarel

$45 million Series A funding round for our client Genomines

Founded in 2021, Genomines is a deeptech startup that uses biotechnology to reinvent the mining industry. This funding will enable Genomines to (...)

Ipsen announces its intention to acquire ImCheck Therapeutics

19 Listopad, 2025

Denis Bourgarel

Ipsen announces its intention to acquire ImCheck Therapeutics

On October 22, 2025, the biopharmaceutical group Ipsen announced that it had entered into a definitive agreement to acquire ImCheck Therapeutics, a (...)

Ze stejné odbornosti

Obtaining an EP Patent - “Published after but filed before”: dealing with this kind of prior art

6 Únor, 2025

Nadine Rocaboy

Obtaining an EP Patent - “Published after but filed before”: dealing with this kind of prior art

“Published after but filed before”: dealing with this kind of prior art A patent application having a filing date earlier than the filing date of (...)

Obtaining an EP Patent - The divisional Application

9 Leden, 2024

Charlotte Juteau

Obtaining an EP Patent - The divisional Application - #4

Focus: The divisional Application If you want to protect different aspects of an invention described in an initial EP patent application, or if an (...)

Obtaining an EP Patent - After filing: How my patent is granted at the EPO

18 Prosinec, 2023

Charlotte Juteau

After filing: How my patent is granted at the EPO - Obtaining an EP Patent - #3

Focus: After filing – How my patent is granted at the EPO Now that I have filed my application at the European Patent Office (EPO), what happens? (...)

AI : UK High Court Decision Recognizes Technical Contribution of Trained ANN and Diverges From EPO’s Approach

14 Prosinec, 2023

Charlotte Leleu

AI : UK High Court Decision Recognizes Technical Contribution of Trained ANN and Diverges From EPO’s Approach

In a decision issued on November 21, 2023, the UK High Court overturned a previous ruling by the UK Patent Office, which had rejected a patent (...)

Obtaining an EP Patent - Claim examination: My claim is rejected for lacking an inventive step

16 Listopad, 2023

Charlotte Juteau

Focus: Claim examination – My claim is rejected for lacking an inventive step My claim received objection from a European Examiner because it “cannot (...)

Obtaining an EP Patent - Claim drafting: My claim is rejected for missing an essential element

11 Říjen, 2023

Laurence Loumes

Claim drafting: My claim is rejected for missing an essential element - Obtaining an EP Patent - #1

Focus: Claim drafting – My claim is rejected for missing an essential element The EP standpoint A claim, whether initially filed or as an amendment, (...)

UPC procedure: what treatment for patent applications?

2 Červen, 2023

Sandrine Bouvier-Ravon

Procédure devant la JUB : quel(s) traitement(s) pour les demandes de brevet ?

It has been a busy time for patent attorneys registered with the Unified Patent Court ("UPC"), totally overwhelmed by the large number of “opt-out” (...)

Enlarged Board of Appeal of EPO issued its much awaited decision G 2/21 (“plausibility”)

31 Květen, 2023

La Grande Chambre de recours de l’OEB a rendu sa décision très attendue G2/21 (« plausibilité »)

The EPO's Enlarged Board of Appeal recently issued a G 2/21 "plausibility" decision regarding the possibility of taking into account experimental (...)

Kick-off of the Unified Patent Court

21 Březen, 2022

Bertrand Loisel

Unified Patent Court

The Unified Patent Court (UPC) Agreement signed in 2013 is a breakthrough for pan-European patent law. Provisions of the UPC Agreement entered into (...)

Clinical trials : implementation of the new regulation

23 Únor, 2022

Denis Bourgarel

Clinical trials : implementation of the new regulation

Implementation of the new European clinical trials regulation 536/2014 on medicinal products for human use Since January 31, 2022, the Clinical Trial (...)